The therapy of insulin resistance in other diseases besides type 2 diabetes
نویسندگان
چکیده
منابع مشابه
The therapy of insulin resistance in other diseases besides type 2 diabetes
Insulin resistance is a clinical condition shared by many diseases besides type 2 diabetes (T2DM) such as obesity, polycystic ovary syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD). Experimental evidence, produced over the years, suggests that metformin has many benefits in the treatment of these diseases. Metformin is a first-line drug in the treatment of overweight and obese type...
متن کاملThe effects of twelve weeks of combined exercises on GLP-1 and insulin resistance in women with type 2 diabetes
Introdution: The purpose of this study was to investigate the effect of twelve weeks of combined exercise with two patterns (aerobic-resistance and resistance-aerobic) on GLP-1 and insulin resistance in women with type 2 diabetes. Methods: In this practical and semi-experimental study, 42 women with type 2 diabetes were divided into three groups: aerobic-resistance group (n=15), resistance-aer...
متن کاملBasal insulin therapy in type 2 diabetes.
Patients with type 2 diabetes mellitus are usually treated initially with oral antidiabetic agents, but as the disease progresses, most patients eventually require insulin to maintain glucose control. Optimal insulin therapy should mimic the normal physiologic secretion of insulin and minimize the risk of hypoglycemia. This article discusses the role of insulin therapy in patients with type 2 d...
متن کاملInsulin Therapy in Type 2 Diabetes
34.Kelley DE, Henry RR, Edelman SV: Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucosehomeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group. Diabetes Care 19:1237-1242,1996 Abstract 35.Jennings AM, Lewis KS, Murdoch S, et al: Randomized trial comparing continuous subcutaneous insulin infusion and conventional insu...
متن کامل[Early insulin therapy in type 2 diabetes?].
Type 2 diabetes is characterized by progressive decline in pancreatic beta cell function and persistent insulin resistance. Decreased beta cell mass and amyloid deposits in the islet are the pathological hallmark of the disease. Preserved beta cell function is the most important determinant of glucose disposal, even after adjustment for insulin sensitivity, which might modulate beta cell functi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
سال: 2014
ISSN: 1124-4909,1590-1262
DOI: 10.1007/s40519-014-0139-y